Section 6 of 6
References
167 sources
- Abbey (2026) (opens in a new tab)
- Age-Related Eye Disease Study 2 Research Group (2013) (opens in a new tab)
- Age-Related Eye Disease Study Research Group (2001) (opens in a new tab)
- Ahluwalia et al. (2021) (opens in a new tab)
- American Academy of Ophthalmology IRIS63 measure specification (opens in a new tab)
- American Academy of Ophthalmology Medicare payment comparison (2026) (opens in a new tab)
- American Academy of Ophthalmology MIPS 2024 quality changes (2023) (opens in a new tab)
- Anegondi et al. (2025) (opens in a new tab)
- Annexon Biosciences ARCHER enrollment press release (2022) (opens in a new tab)
- Annexon Biosciences ARCHER II enrollment press release (2025) (opens in a new tab)
- Annexon Biosciences ARCHER II expansion press release (2026) (opens in a new tab)
- Annexon Biosciences ARCHER II registrational program press release (2023) (opens in a new tab)
- Annexon Biosciences ARCHER II update press release (2024) (opens in a new tab)
- Annexon Biosciences ARCHER initiation press release (2021) (opens in a new tab)
- Annexon Biosciences ARCHER topline press release (2023) (opens in a new tab)
- Annexon Biosciences ASRS 2023 press release (2023) (opens in a new tab)
- Annexon Biosciences Form 10-K (2021) (opens in a new tab)
- Annexon Biosciences Form 10-K (2026) (opens in a new tab)
- Annexon Biosciences Form 10-Q (2026) (opens in a new tab)
- Annexon Biosciences fourth-quarter 2024 results press release (2025) (opens in a new tab)
- Annexon Biosciences investor event presentation (2026) (opens in a new tab)
- Annexon Biosciences PDC pilot press release (2025) (opens in a new tab)
- Annexon Biosciences PRIME press release (2023) (opens in a new tab)
- Annexon Biosciences Retina Society press release (2026) (opens in a new tab)
- Annexon Biosciences second-quarter 2022 results press release (2022) (opens in a new tab)
- Annexon Biosciences third-quarter 2026 results press release (2026) (opens in a new tab)
- Annexon Biosciences vonaprument presentation (2026) (opens in a new tab)
- Apellis Pharmaceuticals Syfovre prescribing information (2025) (opens in a new tab)
- Astellas Pharma US Izervay prescribing information (2026) (opens in a new tab)
- Baker et al. (2026) (opens in a new tab)
- Bakri et al. (2023) (opens in a new tab)
- Bakri et al. (2024) (opens in a new tab)
- Barakat (2025) (opens in a new tab)
- Barakat (2026) (opens in a new tab)
- Bhavsar et al. (2026) (opens in a new tab)
- Borkar et al. (2025) (opens in a new tab)
- Borkar et al. (2026) (opens in a new tab)
- Boyer et al. (2017) (opens in a new tab)
- Boyer et al. (2024) (opens in a new tab)
- Brown et al. (2000) (opens in a new tab)
- Carlton et al. (2019) (opens in a new tab)
- Caswell et al. (2021) (opens in a new tab)
- Centers for Medicare & Medicaid Services Quality ID 14 (2023) (opens in a new tab)
- Chakravarthy (2026) (opens in a new tab)
- Chakravarthy et al. (2018) (opens in a new tab)
- Chakravarthy et al. (2024) (opens in a new tab)
- Chang (2026) (opens in a new tab)
- ClinicalTrials.gov NCT03488550 (opens in a new tab)
- ClinicalTrials.gov NCT04188015 (opens in a new tab)
- ClinicalTrials.gov NCT04656561 (opens in a new tab)
- ClinicalTrials.gov NCT04656561 results (opens in a new tab)
- ClinicalTrials.gov NCT06510816 (opens in a new tab)
- ClinicalTrials.gov NCT07807969 (opens in a new tab)
- CMS Medicare Part B Payment Limit File (2026) (opens in a new tab)
- CMS Medicare Part B Spending by Drug (2026) (opens in a new tab)
- CMS Medicare Quarterly Part B Spending by Drug (2026) (opens in a new tab)
- Colijn et al. (2017) (opens in a new tab)
- Csaky et al. (2024) (opens in a new tab)
- Cummings Joyner et al. (2023) (opens in a new tab)
- Danzig et al. (2024) (opens in a new tab)
- Dhoot et al. (2026) (opens in a new tab)
- Dinah et al. (2025) (opens in a new tab)
- Eichenbaum (2025) (opens in a new tab)
- Epshtein (2026) (opens in a new tab)
- Eriksen et al. (2025) (opens in a new tab)
- EU CTIS 2024-515022-88-00 (opens in a new tab)
- EURETINA Congress (2024) (opens in a new tab)
- European Medicines Agency Izelvay (2025) (opens in a new tab)
- European Medicines Agency Syfovre (2025) (opens in a new tab)
- Evans and Lawrenson (2023) (opens in a new tab)
- FDA De Novo DEN230083 (2024) (opens in a new tab)
- Fernández-Muro et al. (2026) (opens in a new tab)
- Fidler (2023) (opens in a new tab)
- Fleckenstein et al. (2021) (opens in a new tab)
- Fleckenstein et al. (2024) (opens in a new tab)
- Friedman et al. (2004) (opens in a new tab)
- Gallego-Pinazo (2026) (opens in a new tab)
- GBD 2021 Global AMD Collaborators (2025) (opens in a new tab)
- Goren Fein et al. (2026) (opens in a new tab)
- Grover et al. (2023) (opens in a new tab)
- Guymer et al. (2020) (opens in a new tab)
- Heier et al. (2020) (opens in a new tab)
- Heier et al. (2023) (opens in a new tab)
- Heier et al. (2024) (opens in a new tab)
- Holekamp et al. (2020) (opens in a new tab)
- Holz et al. (2014) (opens in a new tab)
- Hu et al. (2025) (opens in a new tab)
- Jackson et al. (2023) (opens in a new tab)
- Jaffe et al. (2021) (opens in a new tab)
- Jaffe et al. (2024a) (opens in a new tab)
- Jaffe et al. (2024b) (opens in a new tab)
- Jaffe et al. (2026) (opens in a new tab)
- Jiao et al. (2018) (opens in a new tab)
- Joachim et al. (2013) (opens in a new tab)
- Keenan et al. (2018) (opens in a new tab)
- Keenan et al. (2025) (opens in a new tab)
- Khanani et al. (2023) (opens in a new tab)
- Khanani et al. (2026) (opens in a new tab)
- Khurana (2025) (opens in a new tab)
- Khurana et al. (2024) (opens in a new tab)
- Kim et al. (2021) (opens in a new tab)
- Kimel et al. (2016) (opens in a new tab)
- Klein et al. (2008) (opens in a new tab)
- Krogh Nielsen et al. (2023) (opens in a new tab)
- Künzel et al. (2020) (opens in a new tab)
- Künzel et al. (2024) (opens in a new tab)
- Kuriyan et al. (2025) (opens in a new tab)
- Lad (2025) (opens in a new tab)
- Lad et al. (2024) (opens in a new tab)
- Lally (2025) (opens in a new tab)
- Legge (2024) (opens in a new tab)
- Li et al. (2020) (opens in a new tab)
- Li et al. (2026) (opens in a new tab)
- Lindblad et al. (2009) (opens in a new tab)
- Luo et al. (2026) (opens in a new tab)
- McGuinness et al. (2017) (opens in a new tab)
- Mitchell et al. (2018) (opens in a new tab)
- Morga et al. (2023) (opens in a new tab)
- National Institute for Health and Care Excellence pegcetacoplan appraisal (2026) (opens in a new tab)
- Patel et al. (2020) (opens in a new tab)
- Patel et al. (2024a) (opens in a new tab)
- Patel et al. (2024b) (opens in a new tab)
- Paudel et al. (2024) (opens in a new tab)
- Pearlman (2024) (opens in a new tab)
- Pharmaceutical Benefits Advisory Committee avacincaptad pegol (2026) (opens in a new tab)
- Pharmaceutical Benefits Advisory Committee pegcetacoplan (2025) (opens in a new tab)
- Prasad et al. (2026) (opens in a new tab)
- Rahimy et al. (2023) (opens in a new tab)
- Regillo et al. (2024) (opens in a new tab)
- Rein et al. (2022a) (opens in a new tab)
- Rein et al. (2022b) (opens in a new tab)
- Rim et al. (2020) (opens in a new tab)
- Rowe et al. (2026) (opens in a new tab)
- Rudnicka et al. (2015) (opens in a new tab)
- Sadda et al. (2018) (opens in a new tab)
- Sambhara (2026) (opens in a new tab)
- Sarda et al. (2021) (opens in a new tab)
- Sarda et al. (2024) (opens in a new tab)
- Sarraf et al. (2026) (opens in a new tab)
- Saundankar et al. (2025a) (opens in a new tab)
- Saundankar et al. (2025b) (opens in a new tab)
- Schmitz-Valckenberg et al. (2016) (opens in a new tab)
- Sharma (2026) (opens in a new tab)
- Shen et al. (2018) (opens in a new tab)
- Shen et al. (2025) (opens in a new tab)
- Singh et al. (2023) (opens in a new tab)
- Stanga (2025) (opens in a new tab)
- Stanga et al. (2024) (opens in a new tab)
- Sun et al. (2023) (opens in a new tab)
- Sunness et al. (1997) (opens in a new tab)
- Sunness et al. (2007) (opens in a new tab)
- Sunness et al. (2008) (opens in a new tab)
- Tzoumas et al. (2023) (opens in a new tab)
- Vakharia (2025) (opens in a new tab)
- Vangsted et al. (2023) (opens in a new tab)
- Vemulakonda et al. (2025) (opens in a new tab)
- Vujosevic (2025) (opens in a new tab)
- Wang and Ying (2021) (opens in a new tab)
- WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (2026) (opens in a new tab)
- WHO proposed INN List 134 (2025) (opens in a new tab)
- WHO recommended INN List 96 (2026) (opens in a new tab)
- Williams et al. (2026) (opens in a new tab)
- Witkin et al. (2024) (opens in a new tab)
- Wong et al. (2014) (opens in a new tab)
- Wykoff et al. (2025) (opens in a new tab)
- Xin et al. (2018) (opens in a new tab)
- Yednock et al. (2022) (opens in a new tab)